Retinal pigment epithelial tears after intravitreal bevacizumab injection for predominantly classic choroidal neovascularization

European Journal of Ophthalmology

Volumn 17, Issue 6, 2007, Pages 992-995

  Arias, Luis ^a,b   Caminal, J M ^a   Rubio, M ^a   Pujol, O ^a   Arruga, J ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b USP Hospitals   (Spain)

Author keywords

Intravitreal bevacizumab; Predominantly classic choroidal neovascularization; Retinal pigment epithelial tear

Indexed keywords

BEVACIZUMAB;

AGED; ARTICLE; CLINICAL ARTICLE; EARLY TREATMENT DIABETIC RETINOPATHY CHART; EYE EXAMINATION; FLUORESCENCE ANGIOGRAPHY; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA TEAR; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION;

EID: 39349095670     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210701700622     Document Type: Article

References (8)

1. Gelisken F, Inhoffen W, Partsch M, Schneider U, Kreissig I. Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization. Am J Ophthalmol 2001; 131: 518-20.
2. Bressler NM, Finkelstein D, Sunness JS, et al. Retinal pigment epithelial tears through the fovea with preservation of good visual acuity. Arch Ophthalmol 1990; 108: 1694-7.
3. Michels S, Aue A, Simader C, et al. Retinal pigment epithelium tears following verteporfin therapy combined with intravitreal triamcinolone. Am J Ophthalmol 2006; 141: 396-8.
4. Dhalla MS, Blinder KJ, Tewari A, et al. Retinal pigment epithelial tear following intravitreal pegaptanib sodium. Am J Ophthalmol 2006; 141: 752-4.
5. Meyer CH, Mennel S, Schmidt JC, Kroll P. Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularization secondary to age-related macular degeneration. Br J Ophthalmol 2006; 90: 1207-8.
6. Nicolo M, Ghiglione D, Calabria G. Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin). Eur J Ophthalmol 2006; 16: 770-3.
7. Spandau UH, Jonas JB. Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration. Am J Ophthalmol 2006; 142: 1068-70.
8. Gamulescu MA, Framme C, Sachs H. Retinal pigment epithelial rip after intravitreal bevacizumab (Avastin) treatment for vascularised pigment epithelial detachment secondary to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2007; 245: 1037-40.